[HTML][HTML] New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments
…, C Ronco, O Camara, D Ambrosetti, A Hagege… - Theranostics, 2019 - ncbi.nlm.nih.gov
Clear cell Renal Cell (RCC) and Head and Neck Squamous Cell Carcinomas (HNSCC) are
characterized by a pro-angiogenic/pro-inflammatory context. Despite conventional or …
characterized by a pro-angiogenic/pro-inflammatory context. Despite conventional or …
Synthesis and biological evaluation of 3-amino-1, 2, 4-triazole derivatives as potential anticancer compounds
…, M Penco-Campillo, M Dufies, A Hagege… - Bioorganic …, 2020 - Elsevier
Two series of compounds carrying 3-amino-1,2,4-triazole scaffold were synthesized and
evaluated for their anticancer activity against a panel of cancer cell lines using XTT assay. The 1…
evaluated for their anticancer activity against a panel of cancer cell lines using XTT assay. The 1…
[PDF][PDF] Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma
A Hagege, E Saada-Bouzid, D Ambrosetti… - Cell Reports …, 2022 - cell.com
Local or metastatic relapse following surgery, radiotherapy, and cisplatin is the leading
cause of death in patients with head and neck squamous cell carcinoma (HNSCC). Our study …
cause of death in patients with head and neck squamous cell carcinoma (HNSCC). Our study …
[HTML][HTML] Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
…, X He, N Nottet, W Souleyreau, A Hagege… - Communications …, 2021 - nature.com
Polo-like kinase 1 (Plk1) expression is inversely correlated with survival advantages in
many cancers. However, molecular mechanisms that underlie Plk1 expression are poorly …
many cancers. However, molecular mechanisms that underlie Plk1 expression are poorly …
Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma
C Montemagno, A Hagege, D Borchiellini… - …, 2020 - Taylor & Francis
Metastatic clear cell renal cell carcinoma (mccRCC) benefits from several treatment options
in the first-line setting with VEGFR inhibitors and/or immunotherapy including anti-PD-L1 or …
in the first-line setting with VEGFR inhibitors and/or immunotherapy including anti-PD-L1 or …
[HTML][HTML] The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and …
A Hagege, D Ambrosetti, J Boyer, A Bozec, J Doyen… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Head and neck squamous cell carcinoma (HNSCC) represent the 4 th most
aggressive cancer. 50% of patients relapse to the current treatments combining surgery, …
aggressive cancer. 50% of patients relapse to the current treatments combining surgery, …
Nouvelles stratégies thérapeutiques dans les carcinomes épidermoïdes des voies aéro-digestives supérieures
A Hagege - 2022 - theses.hal.science
Les carcinomes des voies aéro-digestives supérieures (VADS) représentent le 5ème cancer
le plus agressif au monde. Des résistances innées ou acquises entrainent des rechutes …
le plus agressif au monde. Des résistances innées ou acquises entrainent des rechutes …
Cabozantinib, a Promising Therapeutic Strategy for Resistant Head and Neck Squamous Cell Carcinoma Patients
A Hagege, O Rastoin, D Ambrosetti, J Boyer… - Available at SSRN … - papers.ssrn.com
Local or metastatic relapses following surgery, radiotherapy and chemotherapy (cisplatin)
are the leading causes of death of patients with head and neck squamous cell carcinoma (…
are the leading causes of death of patients with head and neck squamous cell carcinoma (…
A novel mechanism of HIF2-dependent PLK1-mediated metastasis and drug resistance of clear cell Renal Cell Carcinoma
…, J Viotti, X He, N Nottet, W Souleyreau, A Hagege… - medRxiv, 2020 - medrxiv.org
Polo-Like Kinase 1 (Plk1) expression is inversely correlated with survival advantages in
many cancers. However, molecular mechanisms that underlie Plk1 expression are poorly …
many cancers. However, molecular mechanisms that underlie Plk1 expression are poorly …
Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors
Aims We have shown that extracellular vesicles (EVs) secreted by embryonic stem cell-derived
cardiovascular progenitor cells (Pg) recapitulate the therapeutic effects of their parent …
cardiovascular progenitor cells (Pg) recapitulate the therapeutic effects of their parent …
